AI-based Pathology Market Size, Share & Trends Analysis Report by Component (Software, Hardware, Services), Technology, Deployment Mode, Pathology Type, Imaging Modality, Disease Area, Application, End User, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2026–2035
|
|
|
Segmental Data Insights |
|
|
Demand Trends |
|
|
Competitive Landscape |
|
|
Strategic Development |
|
|
Future Outlook & Opportunities |
|
AI-based Pathology Market Size, Share, and Growth
The global AI-based Pathology market is witnessing strong growth, valued at USD 0.1 billion in 2025 and projected to reach USD 0.8 billion by 2035, expanding at a CAGR of 21.6% during the forecast period.
Matt Sause, CEO of Roche Diagnostics, said, “Digital pathology has the potential to improve precision diagnosis of cancer and enable physicians to offer better tailored treatment regimens, ringing PathAI into Roche Diagnostics will allow us to combine their best-in-class digital pathology tools with our leading oncology diagnosis platforms to deliver better insights for physicians and potentially better outcomes for patients worldwide.”
The rising adoption of digital pathology, expanding need for timely cancer diagnosis with high precision, and escalating use of AI in the lab processes are the key factors propelling the AI-based Pathology market. The AI algorithms enrich the analysis of whole slide images, increase the consistency of diagnosis, decrease pathologist workload, and facilitate precision medicine by automatically characterizing tissues.
Healthcare organizations are picking up the pace in their investment in cloud-based pathology platforms, tackling the workforce gap and streamlining diagnostic workflows. For instance, Roche Holding AG expanded the capabilities of its digital pathology portfolio with AI-powered image analysis applications to support pathology laboratories and cancer diagnosis. Likewise, Koninklijke Philips N.V. is further developing the digital pathology platform as an AI-driven system for increased workflow automation and better image management, facilitating more rapid collaboration and diagnostic decision making.
Adjacent opportunities for the AI-based pathology market include digital pathology platforms, AI-powered radiology, precision oncology, biomarker discovery, and clinical decision support systems. These markets benefit from shared AI infrastructure, image analytics, genomic integration, and workflow automation, enabling broader adoption of data-driven diagnostics, personalized treatment planning, and connected healthcare ecosystems.
AI-based Pathology Market Dynamics and Trends
Driver: Growing Demand for Faster and More Accurate Diagnostics
- The rising number of complex diseases such as cancer is causing a greater need for faster and more accurate diagnostics. By leveraging artificial intelligence, this approach to pathology allows for whole-slide image analysis and can cut down on the diagnostic variability that can occur among different pathologists, as well as help pathologists identify abnormalities faster and more reliably, thereby aiding in better clinical decision-making and patient outcomes.
- Healthcare providers are increasingly turning to AI-powered platforms for pathology in order to cut down turnaround time, deal with the rising complexity of modern diagnostic workload, and enable precision medicine. AI is becoming increasingly a part of the modern workflow in pathology, with these solutions increasing laboratory efficiency by making image interpretation more efficient and helping to detect disease earlier.
- The increasing demand for fast and accurate diagnostics is further driving the market's growth by utilizing AI in pathology, thereby enhancing diagnostic accuracy and efficiency.
Restraint: Limited Availability of Standardized Annotated Pathology Datasets Restricts AI Model Performance
- The AI-based Pathology market is hampered by the scarcity of standardized, high-quality annotated pathology datasets to develop and validate accurate AI algorithms. There are inconsistencies between healthcare institutions because of varying slide preparation methods, staining procedures, scanner technologies and image formats, which hinder the accuracy of the models and interoperability.
- Furthermore, the acquisition of large, diverse and clinically validated datasets is limited by patient privacy laws, data sharing restrictions and the time-consuming process of expert pathologists annotating them. These factors impose additional costs on AI development, extend the development process for regulatory approval, and delay the commercialization of solutions especially those designed for multiple disease types and healthcare settings.
- Lack of access to standardized pathology datasets is hindering AI innovation, slowing large scale deployment and limiting wider market adoption.
Opportunity: Expansion of AI-Enabled Companion Diagnostics Accelerates Precision Oncology and Personalized Medicine
- AI is providing enormous opportunities for precision medicine, as it allows for precise identification of disease biomarkers and aids in companion diagnostics. AI-based pathology platforms provide greater speed and uniformity in tissue and biomarker analysis that aids in identifying targeted therapies for patients.
- AI-based pathology solutions are commercializing at an increasing pace thanks to a growing number of partnerships between the pharmaceutical industry, diagnostic developers and healthcare providers, all contributing to the integration of AI into oncology drug development and personalized treatment planning.
- Paige AI, Inc. added to its AI-powered pathology offering with HER2Complete and the Paige Prostate Suite to further enhance AI-enabled companion diagnostics, enabling biomarker assessment and cancer classification in precision oncology.
- The growth of AI-powered companion diagnostics is driving increased uptake of precision oncology, fueling AI-powered pathology platforms and personalized health services.
Key Trend: Rapid Evolution of Multimodal AI Platforms Combining Pathology, Imaging, and Genomic Data
- The use of multimodal AI platforms combining digital pathology images with radiology, genomics, and clinical data is gaining traction in healthcare for comprehensive diagnostic insights.
- This approach will improve the characterization of diseases, identification of biomarkers, and treatment planning for complex diseases, especially cancer.
- In June 2026, Tempus AI, Inc. announced it had formed an Open-Source Digital Pathology Consortium with Yale New Haven Hospital and Memorial Sloan Kettering Cancer Center to further create and connect AI-enabled image management, biomarker analysis, and pathology workflows to facilitate more rapid, standardized precision diagnostics.
- The integration of pathology, imaging, and genomics is creating a new space of precision medicine, which is enhancing clinical decision making, and accelerating the use of AI-based diagnostic ecosystems in health care institutions.
AI-based Pathology Market Analysis and Segmental Data
Cancer Diagnosis Dominate Global AI-based Pathology Market
- Cancer diagnosis is the largest segment of AI-based Pathology market because of the high occurrence of cancer worldwide and the need for speedy and accurate pathological diagnosis in a standardized manner. AI-driven pathology solutions boost the identification of tumors, their grading, the analysis of biomarkers, and the categorization of tissues, empowering pathologists to make more accurate diagnoses and provide tailored treatment.
- The unrestricted use of digital pathology, companion diagnostics, and precision oncology is further bolstering this segment. AI is increasingly being used by healthcare organizations to cut down the time required to reach a diagnosis, optimize workflows, and ensure that diagnostics are consistent in cancer laboratories.
- AI is gaining momentum in the field of cancer diagnostics, fueling innovation in precision oncology and ensuring continued market expansion.
North America Leads Global AI-based Pathology Market Demand
- The AI-based Pathology market is the leading in North America, supported by its well-developed healthcare facilities, high penetration of digital pathology, and substantial investments in artificial intelligence-powered diagnostics. Pathology laboratories and hospital networks are rapidly transforming, the prevalence of cancer is high, and the demand for personalized medicine is growing in the region.
- Presence of leading AI pathology developers, existing diagnostic companies, supportive regulatory pathways, and wide adoption of whole-slide imaging technologies further fortifies regional market dominance. The region is seeing innovation and scale-up of AI-powered pathology solutions being driven by collaborative efforts by healthcare providers, research institutions and technology companies.
- North America's leadership is accelerating global commercialization of AI-based pathology technologies and setting benchmarks for precision diagnostics and digital pathology adoption.
AI-based Pathology Market Ecosystem
The global AI-based Pathology market is consolidated, led by key players such as F. Hoffmann-La Roche Ltd., Leica Biosystems Nussloch GmbH, Koninklijke Philips N.V., Siemens Healthineers AG, and Hamamatsu Photonics K.K. These companies strengthen their market position through innovations in digital pathology, whole-slide imaging, AI-powered image analysis, and computational pathology, supported by strategic collaborations and continuous investments in precision diagnostics.
The value chain begins with whole-slide imaging systems, AI algorithms, digital pathology software, cloud infrastructure, and LIS integration, followed by AI model development, validation, regulatory compliance, and deployment. AI-based pathology solutions enable automated tissue analysis, cancer detection, biomarker assessment, and workflow optimization, while continuous software upgrades and cybersecurity ensure reliable performance.
The market has moderate-to-high entry barriers due to stringent regulations, high R&D costs, large annotated dataset requirements, and integration complexity. Leading companies maintain their position through proprietary AI platforms, strong clinical partnerships, and continuous innovation in digital pathology and precision oncology.
Recent Development and Strategic Overview
- In May 2026, F. Hoffmann-La Roche Ltd. agreed to acquire PathAI to strengthen its digital pathology portfolio by integrating AI-powered image management, workflow automation, and companion diagnostics, enhancing precision oncology and laboratory efficiency.
- In July 2026, Artera received U.S. FDA clearance for ArteraAI Breast, the first digital pathology-based AI tool for breast cancer risk stratification, expanding its AI platform to support precision oncology and personalized treatment decisions through routine pathology workflows.
Report Scope
|
Detail |
|
|
Market Size in 2025 |
USD 0.1 Bn |
|
Market Forecast Value in 2035 |
USD 0.8 Bn |
|
Growth Rate (CAGR) |
21.6% |
|
Forecast Period |
2026 – 2035 |
|
Historical Data Available for |
2021 – 2024 |
|
Market Size Units |
US$ Billion for Value |
|
Report Format |
Electronic (PDF) + Excel |
|
North America |
Europe |
Asia Pacific |
Middle East |
Africa |
South America |
|
|
|
|
|
|
|
Companies Covered |
|||||
|
|||||
AI-based Pathology Market Segmentation and Highlights
|
Segment |
Sub-segment |
|
AI-based Pathology Market, By Component |
|
|
AI-based Pathology Market, By Technology |
|
|
AI-based Pathology Market, By Deployment Mode |
|
|
AI-based Pathology Market, By Pathology Type |
|
|
AI-based Pathology Market, By Imaging Modality |
|
|
AI-based Pathology Market, By Disease Area |
|
|
AI-based Pathology Market, By Application |
|
|
AI-based Pathology Market, By End-user |
|
Frequently Asked Questions
Table of Contents
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Sources
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Sources
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. Global AI-based Pathology Market Outlook
- 2.1.1. AI-based Pathology Market Size (Value - US$ Bn), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End-use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2026-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 2.1. Global AI-based Pathology Market Outlook
- 3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
- 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Rising demand for faster and more accurate diagnostic workflows
- 4.1.1.2. Growing adoption of digital pathology and AI-powered image analysis
- 4.1.1.3. Increasing prevalence of cancer and chronic diseases requiring precise diagnostics.
- 4.1.2. Restraints
- 4.1.2.1. High implementation and integration costs of AI pathology platforms
- 4.1.2.2. Data privacy concerns and stringent regulatory approval requirements.
- 4.1.1. Drivers
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Ecosystem Analysis
- 4.5. Porter’s Five Forces Analysis
- 4.6. PESTEL Analysis
- 4.7. Global AI-based Pathology Market Demand
- 4.7.1. Historical Market Size – in Value (US$ Bn), 2020-2024
- 4.7.2. Current and Future Market Size – in Value (US$ Bn), 2026–2035
- 4.7.2.1. Y-o-Y Growth Trends
- 4.7.2.2. Absolute $ Opportunity Assessment
- 4.1. Market Dynamics
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 5.1. Competition structure
- 6. Global AI-based Pathology Market Analysis, by Component
- 6.1. Key Segment Analysis
- 6.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
- 6.2.1. Software
- 6.2.1.1. Digital Pathology Software
- 6.2.1.2. AI Image Analysis Software
- 6.2.1.3. Whole Slide Imaging (WSI) Software
- 6.2.1.4. Clinical Decision Support Software
- 6.2.1.5. Laboratory Information Management System (LIMS) Software
- 6.2.1.6. Workflow Management Software
- 6.2.1.7. Analytics & Reporting Software
- 6.2.1.8. Cloud-Based Pathology Platforms
- 6.2.1.9. Others
- 6.2.2. Hardware
- 6.2.2.1. Whole Slide Scanners
- 6.2.2.2. Digital Microscopes
- 6.2.2.3. AI Servers & Workstations
- 6.2.2.4. High-Performance Computing (HPC) Systems
- 6.2.2.5. Data Storage Systems
- 6.2.2.6. Imaging Cameras
- 6.2.2.7. Display & Visualization Systems
- 6.2.2.8. Networking & Connectivity Devices
- 6.2.2.9. Others
- 6.2.3. Services
- 6.2.3.1. Consulting Services
- 6.2.3.2. System Integration & Deployment Services
- 6.2.3.3. AI Development & Customization Services
- 6.2.3.4. Cloud & Managed Services
- 6.2.3.5. Technical Support & Maintenance
- 6.2.3.6. Training & Education Services
- 6.2.3.7. Data Management Services
- 6.2.3.8. Regulatory & Compliance Services
- 6.2.3.9. Others
- 6.2.1. Software
- 7. Global AI-based Pathology Market Analysis, by Technology
- 7.1. Key Segment Analysis
- 7.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
- 7.2.1. Machine Learning (ML)
- 7.2.2. Deep Learning
- 7.2.3. Computer Vision
- 7.2.4. Natural Language Processing (NLP)
- 7.2.5. Generative AI
- 7.2.6. Predictive Analytics
- 7.2.7. Image Analysis Algorithms
- 7.2.8. Cloud Computing
- 7.2.9. Others
- 8. Global AI-based Pathology Market Analysis, by Deployment Mode
- 8.1. Key Segment Analysis
- 8.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
- 8.2.1. Cloud-Based
- 8.2.2. On-Premises
- 8.2.3. Hybrid
- 9. Global AI-based Pathology Market Analysis, by Pathology Type
- 9.1. Key Segment Analysis
- 9.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Pathology Type, 2021-2035
- 9.2.1. Anatomical Pathology
- 9.2.2. Clinical Pathology
- 9.2.3. Molecular Pathology
- 9.2.4. Digital Pathology
- 9.2.5. Forensic Pathology
- 9.2.6. Hematopathology
- 9.2.7. Cytopathology
- 9.2.8. Histopathology
- 9.2.9. Others
- 10. Global AI-based Pathology Market Analysis, by Imaging Modality
- 10.1. Key Segment Analysis
- 10.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Imaging Modality, 2021-2035
- 10.2.1. Whole Slide Imaging (WSI)
- 10.2.2. Brightfield Imaging
- 10.2.3. Fluorescence Imaging
- 10.2.4. Immunohistochemistry (IHC) Imaging
- 10.2.5. Digital Microscopy
- 10.2.6. Multiplex Imaging
- 10.2.7. Cytology Imaging
- 10.2.8. Others
- 11. Global AI-based Pathology Market Analysis, by Disease Area
- 11.1. Key Segment Analysis
- 11.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Disease Area, 2021-2035
- 11.2.1. Oncology
- 11.2.2. Infectious Diseases
- 11.2.3. Neurology
- 11.2.4. Cardiology
- 11.2.5. Dermatology
- 11.2.6. Gastroenterology
- 11.2.7. Nephrology
- 11.2.8. Hematological Disorders
- 11.2.9. Others
- 12. Global AI-based Pathology Market Analysis, by Application
- 12.1. Key Segment Analysis
- 12.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
- 12.2.1. Cancer Diagnosis
- 12.2.2. Disease Detection & Classification
- 12.2.3. Biomarker Discovery
- 12.2.4. Drug Discovery & Development
- 12.2.5. Companion Diagnostics
- 12.2.6. Laboratory Workflow Automation
- 12.2.7. Clinical Decision Support
- 12.2.8. Research & Education
- 12.2.9. Quality Control & Assurance
- 12.2.10. Others
- 13. Global AI-based Pathology Market Analysis, by End User
- 13.1. Key Segment Analysis
- 13.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
- 13.2.1. Hospitals
- 13.2.2. Diagnostic Laboratories
- 13.2.3. Academic & Research Institutes
- 13.2.4. Pharmaceutical & Biotechnology Companies
- 13.2.5. Contract Research Organizations (CROs)
- 13.2.6. Reference Laboratories
- 13.2.7. Cancer Research Centers
- 13.2.8. Specialty Clinics
- 13.2.9. Others
- 14. Global AI-based Pathology Market Analysis, by Region
- 14.1. Key Findings
- 14.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
- 14.2.1. North America
- 14.2.2. Europe
- 14.2.3. Asia Pacific
- 14.2.4. Middle East
- 14.2.5. Africa
- 14.2.6. South America
- 15. North America AI-based Pathology Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. North America AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 15.3.1. Component
- 15.3.2. Technology
- 15.3.3. Deployment Mode
- 15.3.4. Pathology Type
- 15.3.5. Imaging Modality
- 15.3.6. Disease Area
- 15.3.7. Application
- 15.3.8. End User
- 15.3.9. Country
- 15.3.9.1. USA
- 15.3.9.2. Canada
- 15.3.9.3. Mexico
- 15.4. USA AI-based Pathology Market
- 15.4.1. Country Segmental Analysis
- 15.4.2. Component
- 15.4.3. Technology
- 15.4.4. Deployment Mode
- 15.4.5. Pathology Type
- 15.4.6. Imaging Modality
- 15.4.7. Disease Area
- 15.4.8. Application
- 15.4.9. End User
- 15.5. Canada AI-based Pathology Market
- 15.5.1. Country Segmental Analysis
- 15.5.2. Component
- 15.5.3. Technology
- 15.5.4. Deployment Mode
- 15.5.5. Pathology Type
- 15.5.6. Imaging Modality
- 15.5.7. Disease Area
- 15.5.8. Application
- 15.5.9. End User
- 15.6. Mexico AI-based Pathology Market
- 15.6.1. Country Segmental Analysis
- 15.6.2. Component
- 15.6.3. Technology
- 15.6.4. Deployment Mode
- 15.6.5. Pathology Type
- 15.6.6. Imaging Modality
- 15.6.7. Disease Area
- 15.6.8. Application
- 15.6.9. End User
- 16. Europe AI-based Pathology Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Europe AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 16.3.1. Component
- 16.3.2. Technology
- 16.3.3. Deployment Mode
- 16.3.4. Pathology Type
- 16.3.5. Imaging Modality
- 16.3.6. Disease Area
- 16.3.7. Application
- 16.3.8. End User
- 16.3.9. Country
- 16.3.9.1. Germany
- 16.3.9.2. United Kingdom
- 16.3.9.3. France
- 16.3.9.4. Italy
- 16.3.9.5. Spain
- 16.3.9.6. Netherlands
- 16.3.9.7. Nordic Countries
- 16.3.9.8. Poland
- 16.3.9.9. Russia & CIS
- 16.3.9.10. Rest of Europe
- 16.4. Germany AI-based Pathology Market
- 16.4.1. Country Segmental Analysis
- 16.4.2. Component
- 16.4.3. Technology
- 16.4.4. Deployment Mode
- 16.4.5. Pathology Type
- 16.4.6. Imaging Modality
- 16.4.7. Disease Area
- 16.4.8. Application
- 16.4.9. End User
- 16.5. United Kingdom AI-based Pathology Market
- 16.5.1. Country Segmental Analysis
- 16.5.2. Component
- 16.5.3. Technology
- 16.5.4. Deployment Mode
- 16.5.5. Pathology Type
- 16.5.6. Imaging Modality
- 16.5.7. Disease Area
- 16.5.8. Application
- 16.5.9. End User
- 16.6. France AI-based Pathology Market
- 16.6.1. Country Segmental Analysis
- 16.6.2. Component
- 16.6.3. Technology
- 16.6.4. Deployment Mode
- 16.6.5. Pathology Type
- 16.6.6. Imaging Modality
- 16.6.7. Disease Area
- 16.6.8. Application
- 16.6.9. End User
- 16.7. Italy AI-based Pathology Market
- 16.7.1. Country Segmental Analysis
- 16.7.2. Component
- 16.7.3. Technology
- 16.7.4. Deployment Mode
- 16.7.5. Pathology Type
- 16.7.6. Imaging Modality
- 16.7.7. Disease Area
- 16.7.8. Application
- 16.7.9. End User
- 16.8. Spain AI-based Pathology Market
- 16.8.1. Country Segmental Analysis
- 16.8.2. Component
- 16.8.3. Technology
- 16.8.4. Deployment Mode
- 16.8.5. Pathology Type
- 16.8.6. Imaging Modality
- 16.8.7. Disease Area
- 16.8.8. Application
- 16.8.9. End User
- 16.9. Netherlands AI-based Pathology Market
- 16.9.1. Country Segmental Analysis
- 16.9.2. Component
- 16.9.3. Technology
- 16.9.4. Deployment Mode
- 16.9.5. Pathology Type
- 16.9.6. Imaging Modality
- 16.9.7. Disease Area
- 16.9.8. Application
- 16.9.9. End User
- 16.10. Nordic Countries AI-based Pathology Market
- 16.10.1. Country Segmental Analysis
- 16.10.2. Component
- 16.10.3. Technology
- 16.10.4. Deployment Mode
- 16.10.5. Pathology Type
- 16.10.6. Imaging Modality
- 16.10.7. Disease Area
- 16.10.8. Application
- 16.10.9. End User
- 16.11. Poland AI-based Pathology Market
- 16.11.1. Component
- 16.11.2. Component
- 16.11.3. Technology
- 16.11.4. Deployment Mode
- 16.11.5. Pathology Type
- 16.11.6. Imaging Modality
- 16.11.7. Disease Area
- 16.11.8. Application
- 16.11.9. End User
- 16.12. Russia & CIS AI-based Pathology Market
- 16.12.1. Country Segmental Analysis
- 16.12.2. Component
- 16.12.3. Technology
- 16.12.4. Deployment Mode
- 16.12.5. Pathology Type
- 16.12.6. Imaging Modality
- 16.12.7. Disease Area
- 16.12.8. Application
- 16.12.9. End User
- 16.13. Rest of Europe AI-based Pathology Market
- 16.13.1. Country Segmental Analysis
- 16.13.2. Component
- 16.13.3. Technology
- 16.13.4. Deployment Mode
- 16.13.5. Pathology Type
- 16.13.6. Imaging Modality
- 16.13.7. Disease Area
- 16.13.8. Application
- 16.13.9. End User
- 17. Asia Pacific AI-based Pathology Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Asia Pacific AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 17.3.1. Component
- 17.3.2. Technology
- 17.3.3. Deployment Mode
- 17.3.4. Pathology Type
- 17.3.5. Imaging Modality
- 17.3.6. Disease Area
- 17.3.7. Application
- 17.3.8. End User
- 17.3.9. Country
- 17.3.9.1. China
- 17.3.9.2. India
- 17.3.9.3. Japan
- 17.3.9.4. South Korea
- 17.3.9.5. Australia and New Zealand
- 17.3.9.6. Indonesia
- 17.3.9.7. Malaysia
- 17.3.9.8. Thailand
- 17.3.9.9. Vietnam
- 17.3.9.10. Rest of Asia Pacific
- 17.4. China AI-based Pathology Market
- 17.4.1. Country Segmental Analysis
- 17.4.2. Component
- 17.4.3. Technology
- 17.4.4. Deployment Mode
- 17.4.5. Pathology Type
- 17.4.6. Imaging Modality
- 17.4.7. Disease Area
- 17.4.8. Application
- 17.4.9. End User
- 17.5. India AI-based Pathology Market
- 17.5.1. Country Segmental Analysis
- 17.5.2. Component
- 17.5.3. Technology
- 17.5.4. Deployment Mode
- 17.5.5. Pathology Type
- 17.5.6. Imaging Modality
- 17.5.7. Disease Area
- 17.5.8. Application
- 17.5.9. End User
- 17.6. Japan AI-based Pathology Market
- 17.6.1. Country Segmental Analysis
- 17.6.2. Component
- 17.6.3. Technology
- 17.6.4. Deployment Mode
- 17.6.5. Pathology Type
- 17.6.6. Imaging Modality
- 17.6.7. Disease Area
- 17.6.8. Application
- 17.6.9. End User
- 17.7. South Korea AI-based Pathology Market
- 17.7.1. Country Segmental Analysis
- 17.7.2. Component
- 17.7.3. Technology
- 17.7.4. Deployment Mode
- 17.7.5. Pathology Type
- 17.7.6. Imaging Modality
- 17.7.7. Disease Area
- 17.7.8. Application
- 17.7.9. End User
- 17.8. Australia and New Zealand AI-based Pathology Market
- 17.8.1. Country Segmental Analysis
- 17.8.2. Component
- 17.8.3. Technology
- 17.8.4. Deployment Mode
- 17.8.5. Pathology Type
- 17.8.6. Imaging Modality
- 17.8.7. Disease Area
- 17.8.8. Application
- 17.8.9. End User
- 17.9. End User Indonesia AI-based Pathology Market
- 17.9.1. Country Segmental Analysis
- 17.9.2. Component
- 17.9.3. Technology
- 17.9.4. Deployment Mode
- 17.9.5. Pathology Type
- 17.9.6. Imaging Modality
- 17.9.7. Disease Area
- 17.9.8. Application
- 17.9.9. End User
- 17.10. Malaysia AI-based Pathology Market
- 17.10.1. Country Segmental Analysis
- 17.10.2. Component
- 17.10.3. Technology
- 17.10.4. Deployment Mode
- 17.10.5. Pathology Type
- 17.10.6. Imaging Modality
- 17.10.7. Disease Area
- 17.10.8. Application
- 17.10.9. End User
- 17.11. Thailand AI-based Pathology Market
- 17.11.1. Country Segmental Analysis
- 17.11.2. Component
- 17.11.3. Technology
- 17.11.4. Deployment Mode
- 17.11.5. Pathology Type
- 17.11.6. Imaging Modality
- 17.11.7. Disease Area
- 17.11.8. Application
- 17.11.9. End User
- 17.12. Vietnam AI-based Pathology Market
- 17.12.1. Country Segmental Analysis
- 17.12.2. Component
- 17.12.3. Technology
- 17.12.4. Deployment Mode
- 17.12.5. Pathology Type
- 17.12.6. Imaging Modality
- 17.12.7. Disease Area
- 17.12.8. Application
- 17.12.9. End User
- 17.13. Rest of Asia Pacific AI-based Pathology Market
- 17.13.1. Country Segmental Analysis
- 17.13.2. Component
- 17.13.3. Technology
- 17.13.4. Deployment Mode
- 17.13.5. Pathology Type
- 17.13.6. Imaging Modality
- 17.13.7. Disease Area
- 17.13.8. Application
- 17.13.9. End User
- 18. Middle East AI-based Pathology Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Middle East AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 18.3.1. Component
- 18.3.2. Technology
- 18.3.3. Deployment Mode
- 18.3.4. Pathology Type
- 18.3.5. Imaging Modality
- 18.3.6. Disease Area
- 18.3.7. Application
- 18.3.8. End User
- 18.3.9. Country
- 18.3.9.1. Turkey
- 18.3.9.2. UAE
- 18.3.9.3. Saudi Arabia
- 18.3.9.4. Israel
- 18.3.9.5. Rest of Middle East
- 18.4. Turkey AI-based Pathology Market
- 18.4.1. Country Segmental Analysis
- 18.4.2. Component
- 18.4.3. Technology
- 18.4.4. Deployment Mode
- 18.4.5. Pathology Type
- 18.4.6. Imaging Modality
- 18.4.7. Disease Area
- 18.4.8. Application
- 18.4.9. End User
- 18.5. UAE AI-based Pathology Market
- 18.5.1. Country Segmental Analysis
- 18.5.2. Component
- 18.5.3. Technology
- 18.5.4. Deployment Mode
- 18.5.5. Pathology Type
- 18.5.6. Imaging Modality
- 18.5.7. Disease Area
- 18.5.8. Application
- 18.5.9. End User
- 18.6. Saudi Arabia AI-based Pathology Market
- 18.6.1. Country Segmental Analysis
- 18.6.2. Component
- 18.6.3. Technology
- 18.6.4. Deployment Mode
- 18.6.5. Pathology Type
- 18.6.6. Imaging Modality
- 18.6.7. Disease Area
- 18.6.8. Application
- 18.6.9. End User
- 18.7. Israel AI-based Pathology Market
- 18.7.1. Country Segmental Analysis
- 18.7.2. Component
- 18.7.3. Technology
- 18.7.4. Deployment Mode
- 18.7.5. Pathology Type
- 18.7.6. Imaging Modality
- 18.7.7. Disease Area
- 18.7.8. Application
- 18.7.9. End User
- 18.8. Rest of Middle East AI-based Pathology Market
- 18.8.1. Country Segmental Analysis
- 18.8.2. Component
- 18.8.3. Technology
- 18.8.4. Deployment Mode
- 18.8.5. Pathology Type
- 18.8.6. Imaging Modality
- 18.8.7. Disease Area
- 18.8.8. Application
- 18.8.9. End User
- 19. Africa AI-based Pathology Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Africa AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 19.3.1. Component
- 19.3.2. Technology
- 19.3.3. Deployment Mode
- 19.3.4. Pathology Type
- 19.3.5. Imaging Modality
- 19.3.6. Disease Area
- 19.3.7. Application
- 19.3.8. End User
- 19.3.9. Country
- 19.3.9.1. South Africa
- 19.3.9.2. Egypt
- 19.3.9.3. Nigeria
- 19.3.9.4. Algeria
- 19.3.9.5. Rest of Africa
- 19.4. South Africa AI-based Pathology Market
- 19.4.1. Country Segmental Analysis
- 19.4.2. Component
- 19.4.3. Technology
- 19.4.4. Deployment Mode
- 19.4.5. Pathology Type
- 19.4.6. Imaging Modality
- 19.4.7. Disease Area
- 19.4.8. Application
- 19.4.9. End User
- 19.5. Egypt AI-based Pathology Market
- 19.5.1. Country Segmental Analysis
- 19.5.2. Component
- 19.5.3. Technology
- 19.5.4. Deployment Mode
- 19.5.5. Pathology Type
- 19.5.6. Imaging Modality
- 19.5.7. Disease Area
- 19.5.8. Application
- 19.5.9. End User
- 19.6. Nigeria AI-based Pathology Market
- 19.6.1. Country Segmental Analysis
- 19.6.2. Component
- 19.6.3. Technology
- 19.6.4. Deployment Mode
- 19.6.5. Pathology Type
- 19.6.6. Imaging Modality
- 19.6.7. Disease Area
- 19.6.8. Application
- 19.6.9. End User
- 19.7. Algeria AI-based Pathology Market
- 19.7.1. Country Segmental Analysis
- 19.7.2. Component
- 19.7.3. Technology
- 19.7.4. Deployment Mode
- 19.7.5. Pathology Type
- 19.7.6. Imaging Modality
- 19.7.7. Disease Area
- 19.7.8. Application
- 19.7.9. End User
- 19.8. Rest of Africa AI-based Pathology Market
- 19.8.1. Country Segmental Analysis
- 19.8.2. Component
- 19.8.3. Technology
- 19.8.4. Deployment Mode
- 19.8.5. Pathology Type
- 19.8.6. Imaging Modality
- 19.8.7. Disease Area
- 19.8.8. Application
- 19.8.9. End User
- 20. South America AI-based Pathology Market Analysis
- 20.1. Key Segment Analysis
- 20.2. Regional Snapshot
- 20.3. South America AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 20.3.1. Component
- 20.3.2. Technology
- 20.3.3. Deployment Mode
- 20.3.4. Pathology Type
- 20.3.5. Imaging Modality
- 20.3.6. Disease Area
- 20.3.7. Application
- 20.3.8. End User
- 20.3.9. Country
- 20.3.9.1. Brazil
- 20.3.9.2. Argentina
- 20.3.9.3. Rest of South America
- 20.4. Brazil AI-based Pathology Market
- 20.4.1. Country Segmental Analysis
- 20.4.2. Component
- 20.4.3. Technology
- 20.4.4. Deployment Mode
- 20.4.5. Pathology Type
- 20.4.6. Imaging Modality
- 20.4.7. Disease Area
- 20.4.8. Application
- 20.4.9. End User
- 20.5. Argentina AI-based Pathology Market
- 20.5.1. Country Segmental Analysis
- 20.5.2. Component
- 20.5.3. Technology
- 20.5.4. Deployment Mode
- 20.5.5. Pathology Type
- 20.5.6. Imaging Modality
- 20.5.7. Disease Area
- 20.5.8. Application
- 20.5.9. End User
- 20.6. Rest of South America AI-based Pathology Market
- 20.6.1. Country Segmental Analysis
- 20.6.2. Component
- 20.6.3. Technology
- 20.6.4. Deployment Mode
- 20.6.5. Pathology Type
- 20.6.6. Imaging Modality
- 20.6.7. Disease Area
- 20.6.8. Application
- 20.6.9. End User
- 21. Key Players/ Company Profile
- 21.1. Aiforia Technologies Plc.
- 21.1.1. Company Details/ Overview
- 21.1.2. Company Financials
- 21.1.3. Key Customers and Competitors
- 21.1.4. Business/ Industry Portfolio
- 21.1.5. Product Portfolio/ Specification Details
- 21.1.6. Pricing Data
- 21.1.7. Strategic Overview
- 21.1.8. Recent Developments
- 21.2. F. Hoffmann-La Roche Ltd.
- 21.3. Hamamatsu Photonics K.K.
- 21.4. Hologic, Inc.
- 21.5. Indica Labs, Inc.
- 21.6. Koninklijke Philips N.V.
- 21.7. Leica Biosystems Nussloch GmbH
- 21.8. Nucleai Ltd.
- 21.9. PathAI, Inc.
- 21.10. Proscia Inc.
- 21.11. Siemens Healthineers AG
- 21.12. Tempus AI, Inc.
- 21.13. Visiopharm A/S
- 21.14. Other Key Players
- 21.1. Aiforia Technologies Plc.
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
Research Design
Our research design integrates both demand-side and supply-side analysis through a balanced combination of primary and secondary research methodologies. By utilizing both bottom-up and top-down approaches alongside rigorous data triangulation methods, we deliver robust market intelligence that supports strategic decision-making.
MarketGenics' comprehensive research design framework ensures the delivery of accurate, reliable, and actionable market intelligence. Through the integration of multiple research approaches, rigorous validation processes, and expert analysis, we provide our clients with the insights needed to make informed strategic decisions and capitalize on market opportunities.
MarketGenics leverages a dedicated industry panel of experts and a comprehensive suite of paid databases to effectively collect, consolidate, and analyze market intelligence.
Our approach has consistently proven to be reliable and effective in generating accurate market insights, identifying key industry trends, and uncovering emerging business opportunities.
Through both primary and secondary research, we capture and analyze critical company-level data such as manufacturing footprints, including technical centers, R&D facilities, sales offices, and headquarters.
Our expert panel further enhances our ability to estimate market size for specific brands based on validated field-level intelligence.
Our data mining techniques incorporate both parametric and non-parametric methods, allowing for structured data collection, sorting, processing, and cleaning.
Demand projections are derived from large-scale data sets analyzed through proprietary algorithms, culminating in robust and reliable market sizing.
Research Approach
The bottom-up approach builds market estimates by starting with the smallest addressable market units and systematically aggregating them to create comprehensive market size projections.
This method begins with specific, granular data points and builds upward to create the complete market landscape.
Customer Analysis → Segmental Analysis → Geographical Analysis
The top-down approach starts with the broadest possible market data and systematically narrows it down through a series of filters and assumptions to arrive at specific market segments or opportunities.
This method begins with the big picture and works downward to increasingly specific market slices.
TAM → SAM → SOM
Research Methods
Desk / Secondary Research
While analysing the market, we extensively study secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial report. Secondary sources that we utilize are not only the public sources, but it is a combination of Open Source, Associations, Paid Databases, MG Repository & Knowledgebase, and others.
- Company websites, annual reports, financial reports, broker reports, and investor presentations
- National government documents, statistical databases and reports
- News articles, press releases and web-casts specific to the companies operating in the market, Magazines, reports, and others
- We gather information from commercial data sources for deriving company specific data such as segmental revenue, share for geography, product revenue, and others
- Internal and external proprietary databases (industry-specific), relevant patent, and regulatory databases
- Governing Bodies, Government Organizations
- Relevant Authorities, Country-specific Associations for Industries
We also employ the model mapping approach to estimate the product level market data through the players' product portfolio
Primary Research
Primary research/ interviews is vital in analyzing the market. Most of the cases involves paid primary interviews. Primary sources include primary interviews through e-mail interactions, telephonic interviews, surveys as well as face-to-face interviews with the different stakeholders across the value chain including several industry experts.
| Type of Respondents | Number of Primaries |
|---|---|
| Tier 2/3 Suppliers | ~20 |
| Tier 1 Suppliers | ~25 |
| End-users | ~25 |
| Industry Expert/ Panel/ Consultant | ~30 |
| Total | ~100 |
MG Knowledgebase
• Repository of industry blog, newsletter and case studies
• Online platform covering detailed market reports, and company profiles
Forecasting Factors and Models
Forecasting Factors
- Historical Trends – Past market patterns, cycles, and major events that shaped how markets behave over time. Understanding past trends helps predict future behavior.
- Industry Factors – Specific characteristics of the industry like structure, regulations, and innovation cycles that affect market dynamics.
- Macroeconomic Factors – Economic conditions like GDP growth, inflation, and employment rates that affect how much money people have to spend.
- Demographic Factors – Population characteristics like age, income, and location that determine who can buy your product.
- Technology Factors – How quickly people adopt new technology and how much technology infrastructure exists.
- Regulatory Factors – Government rules, laws, and policies that can help or restrict market growth.
- Competitive Factors – Analyzing competition structure such as degree of competition and bargaining power of buyers and suppliers.
Forecasting Models / Techniques
Multiple Regression Analysis
- Identify and quantify factors that drive market changes
- Statistical modeling to establish relationships between market drivers and outcomes
Time Series Analysis – Seasonal Patterns
- Understand regular cyclical patterns in market demand
- Advanced statistical techniques to separate trend, seasonal, and irregular components
Time Series Analysis – Trend Analysis
- Identify underlying market growth patterns and momentum
- Statistical analysis of historical data to project future trends
Expert Opinion – Expert Interviews
- Gather deep industry insights and contextual understanding
- In-depth interviews with key industry stakeholders
Multi-Scenario Development
- Prepare for uncertainty by modeling different possible futures
- Creating optimistic, pessimistic, and most likely scenarios
Time Series Analysis – Moving Averages
- Sophisticated forecasting for complex time series data
- Auto-regressive integrated moving average models with seasonal components
Econometric Models
- Apply economic theory to market forecasting
- Sophisticated economic models that account for market interactions
Expert Opinion – Delphi Method
- Harness collective wisdom of industry experts
- Structured, multi-round expert consultation process
Monte Carlo Simulation
- Quantify uncertainty and probability distributions
- Thousands of simulations with varying input parameters
Research Analysis
Our research framework is built upon the fundamental principle of validating market intelligence from both demand and supply perspectives. This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias.
Demand-Side Analysis: We understand end-user/application behavior, preferences, and market needs along with the penetration of the product for specific application.
Supply-Side Analysis: We estimate overall market revenue, analyze the segmental share along with industry capacity, competitive landscape, and market structure.
Validation & Evaluation
Data triangulation is a validation technique that uses multiple methods, sources, or perspectives to examine the same research question, thereby increasing the credibility and reliability of research findings. In market research, triangulation serves as a quality assurance mechanism that helps identify and minimize bias, validate assumptions, and ensure accuracy in market estimates.
- Data Source Triangulation – Using multiple data sources to examine the same phenomenon
- Methodological Triangulation – Using multiple research methods to study the same research question
- Investigator Triangulation – Using multiple researchers or analysts to examine the same data
- Theoretical Triangulation – Using multiple theoretical perspectives to interpret the same data
Custom Market Research Services
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation